Aurinia Pharmaceuticals Ownership | Who Owns Aurinia Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Aurinia Pharmaceuticals Ownership Summary


Aurinia Pharmaceuticals is owned by 27.50% institutional investors, 6.82% insiders, and 65.67% retail investors. Tang capital management is the largest institutional shareholder, holding 8.16% of AUPH shares. iShares Russell 2000 ETF is the top mutual fund, with 2.18% of its assets in Aurinia Pharmaceuticals shares.

AUPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAurinia Pharmaceuticals27.50%6.82%65.67%
SectorHealthcare Stocks 232.51%10.72%-143.23%
IndustryBiotech Stocks 384.56%10.58%-295.14%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tang capital management11.33M8.16%$125.19M
Blackrock9.27M6.44%$52.94M
Blackrock funding, inc. /de7.93M5.78%$126.45M
Nea management company3.97M2.86%$43.87M
Arrowstreet capital, limited partnership3.39M2.47%$54.03M
State street2.69M1.94%$29.77M
Morgan stanley2.22M1.62%$35.36M
Renaissance1.59M1.16%$25.36M
Geode capital management1.51M1.10%$24.05M
Marshall wace, llp1.48M1.07%$16.39M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management11.33M4.82%$125.19M
Nea management company3.97M2.41%$43.87M
Ironwood investment management114.62K0.77%$1.83M
Hussman strategic advisors105.00K0.40%$1.67M
Wakefield asset management lllp77.89K0.34%$1.24M
Rice hall james & associates542.55K0.33%$6.00M
Precision wealth strategies54.18K0.28%$864.11K
Highmark wealth management35.70K0.23%$569.35K
Navellier & associates111.69K0.20%$1.78M
Virtus fund advisers7.03K0.20%$63.15K

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp1.48M0.02%1.38M
Tang capital management11.33M4.82%1.30M
Two sigma investments, lp1.34M0.02%1.18M
Lsv asset management656.85K0.02%656.85K
Blackrock9.27M0.00%609.18K

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.63M
Rock springs capital management lp---1.18M
Point72 asset management---849.62K
Readystate asset management lp---657.84K
Lazard asset management798.76K0.01%-446.27K

New Positions

HolderShares% AssetsChangeValue
Lsv asset management656.85K0.02%656.85K$10.48M
Voloridge investment management512.57K0.02%512.57K$5.66M
Hood river capital management269.31K0.04%269.31K$2.98M
Los angeles capital management123.49K0.01%123.49K$1.50M
Norges bank114.05K0.00%114.05K$651.20K

Sold Out

HolderChange
Twin peaks wealth advisors-2.00
Vima-25.00
Nelson, van denburg & campbell wealth management group-26.00
Federation des caisses desjardins du quebec-40.00
Stephens consulting-45.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025193-23.41%37,728,298-42.57%271.23%98-9.26%56-38.46%
Sep 30, 2025206-10.04%43,375,015-25.50%311.78%86-14.00%7720.31%
Jun 30, 20252271.79%58,203,989-6.12%412.10%99-1.98%646.67%
Mar 31, 20253-98.60%312,556-99.46%-0.01%1-99.00%--100.00%
Dec 31, 20242106.60%57,561,302-0.09%402.48%9816.67%4911.36%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Russell 2000 ETF2.88M2.18%-
Fidelity Small Cap Index1.18M0.90%-178.29K
iShares Russell 2000 Growth ETF1.04M0.79%-
State St Russell Sm/Mid Cp® Indx SL Cl I833.00K0.63%-
State St Russell Sm/Mid Cp® Indx NL Cl C820.80K0.60%-
iShares Biotechnology ETF715.73K0.54%-
Lazard US Sm Cap Eq WW Dist EUR577.32K0.43%58.09K
Vanguard Russell 2000 ETF555.52K0.42%-44.21K
International Biotechnology Ord534.69K0.41%-
Vanguard Explorer Inv425.41K0.31%134.96K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 05, 2025TANG KEVIN-Buy$2.34M
Aug 01, 2025TANG KEVIN-Buy$10.12M
Aug 04, 2025TANG KEVIN-Buy$1.13M
Aug 01, 2025Keenan Greg Chief Medical OfficerSell$210.00K
Mar 07, 2025Keenan Greg Chief Medical OfficerSell$68.35K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q331
2025 Q2--
2025 Q1610

AUPH Ownership FAQ


Who Owns Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals shareholders are primarily institutional investors at 27.50%, followed by 6.82% insiders and 65.68% retail investors. The average institutional ownership in Aurinia Pharmaceuticals's industry, Biotech Stocks , is 384.56%, which Aurinia Pharmaceuticals falls below.

Who owns the most shares of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals’s largest shareholders are Tang capital management (11.33M shares, 8.16%), Blackrock (9.27M shares, 6.44%), and Blackrock funding, inc. /de (7.93M shares, 5.78%). Together, they hold 20.37% of Aurinia Pharmaceuticals’s total shares outstanding.

Does Blackrock own Aurinia Pharmaceuticals?

Yes, BlackRock owns 6.44% of Aurinia Pharmaceuticals, totaling 9.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 52.94M$. In the last quarter, BlackRock increased its holdings by 609.18K shares, a 7.03% change.

Who is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tang capital management is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.82% of its assets in 11.33M Aurinia Pharmaceuticals shares, valued at 125.19M$.

Who is the top mutual fund holder of Aurinia Pharmaceuticals shares?

iShares Russell 2000 ETF is the top mutual fund holder of Aurinia Pharmaceuticals shares, with 2.18% of its total shares outstanding invested in 2.88M Aurinia Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools